We are live on ! Find out more
PAVMZ

PAVmed Inc. Series Z Warrant
PAVMZ

Delisted

PAVMZ was delisted on the 30th of April, 2025.

Back to rankings

2 hedge funds and large institutions have $28 invested in PAVmed Inc. Series Z Warrant in 2024 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2 → 2 (0)

64% less capital invested

Capital invested by funds: $77 → $28 (-$49)

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$5

Top Sellers

No sellers this quarter

PAVMZ Hedge Fund Activity: Q1 2024 in Review

2 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Series Z Warrant (PAVMZ) for Q1 2024, worth a combined $28 — down 64% from $77 a quarter earlier.

Fund positioning in PAVMZ was balanced in Q1 2024: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, adding an estimated $5.

  • 2 institutional investors held PAVmed Inc. Series Z Warrant (PAVMZ) as of Q1 2024, unchanged from Q4 2023.
  • Funds reported $28 of PAVmed Inc. Series Z Warrant stock for Q1 2024, down 64% quarter-over-quarter.
  • 0 funds opened new PAVmed Inc. Series Z Warrant positions in Q1 2024 and 0 closed out.
  • The largest PAVmed Inc. Series Z Warrant buyer in Q1 2024 was UBS Group, an estimated $5 added.

Based on aggregated 13F filings for Q1 2024.